SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Winfastorlose who wrote (1309443)7/26/2021 3:26:57 PM
From: FJB2 Recommendations

Recommended By
Mick Mørmøny
Winfastorlose

  Read Replies (1) of 1581722
 
PROFESSOR OF VASCULAR BIOLOGY ON VACCINES

threadreaderapp.com

Respiratory vaccines, as currently conceived, can't effectively block viral infection or transmission. There are basic technical limitations. Perhaps, however, they would diminish disease severity, a worthy goal particularly for those at risk of hospitalization and death.


This assumption now seems uncertain, as data rolls in from Britain and Israel. 4-6 months out, relative vaccine efficacy has dropped markedly and the benefit of vaccination in preventing serious illness/death appears muted. This is particularly notable in at risk groups.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News